Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinically Node Negative Breast Cancer Patients Undergoing Breast Conserving Therapy: Sentinel Lymph Node Procedure Versus Follow-Up.

NCT02271828 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT02271828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02271828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinically Node Negative Breast Cancer Patients Undergoing Breast Conserving Therapy: Sentinel Lymph Node Procedure Versus Follow-Up.
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
May 18, 2015
Completion date
August 15, 2026
Enrollment
1,644 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms